Key result
Overexpression of miR-331 significantly reduced the expression of profibrotic genes, cell proliferation, and migration in isoproterenol-treated cardiac myofibroblasts by downregulating the TGFβ/Smad3 signaling pathway.
Why the study?
The TGFβ signaling pathway is an attractive target for anti-fibrotic therapy, but the role of miR-331 in regulating cardiac fibrosis through this pathway required investigation.
Does miR-331 overexpression reduce isoproterenol-induced profibrotic gene expression in cardiac myofibroblasts?
Does miR-331 overexpression reduce isoproterenol-induced profibrotic gene expression in cardiac myofibroblasts?
p-value: p=<0.05
miR-331 inhibits isoproterenol-induced cardiac fibrosis by targeting the TGFβ/smad3 signaling pathway, suggesting a potential therapeutic target for heart failure.
miR-331 modulation warrants preclinical testing in heart failure models; leaves open therapeutic translation from animal cell data.
Cardiac fibrosis in the failing heart is modulated by activated myofibroblasts, and is a pathology marked by their deposition of extracellular matrix proteins. The TGFβ signaling pathway is important in stimulating fibrosis and therefore seems an attractive new target for anti-fibrotic therapy. The relationship between ncRNAs and TGFβ signaling pathway has been extensively studied. Here, we have provided several lines of evidence to prove that the fibrosis process could be regulated by miR-331 through targeting TGFβ signaling. First, bioinformatics analysis and dual luciferase assay validated a direct interaction between the miR-331 and TGFβ-R1 3'UTR sequence which results in the downregulation of TGFβ signaling pathway. Second, miR-331 expression was inversely related to the expression of a number of genes which are involved in extracellular matrix (ECM) production and deposition processes, both in the in vivo and in vitro fibrosis models. Third, in cultured mouse and human cardiac myofibroblasts (CMyoFbs) under ISO treatment, overexpression of miR-331 decreased the expression level of fibrosis-related genes. Consistently, western blot analysis confirmed that miR-331 overexpression ended in both Smad3 and Col1A1 protein level reduction in mouse cardiac myofibroblasts. Finally, flow cytometry analysis, cyclin D1 and D2 gene expression analysis, and wound-healing assay confirmed the inhibitory effect of miR-331 against cell proliferation and migration in ISO-treated cardiac myofibroblasts. Taken together, accumulative results showed that miR-331 reduced the level of fibrosis-related proteins in cardiac myofibroblasts culture via regulating TGFβ signaling pathway.
No takes yet. Share an insight, caveat, or question.
Yousefi et al. (2021) studied Cardiac fibrosis (n=60). miR-331 overexpression vs. Empty pEGFP-CI vector (Mock) was evaluated on Expression of profibrotic genes and TGFβ signaling pathway components (p=<0.05). Overexpression of miR-331 significantly reduced the expression of profibrotic genes, cell proliferation, and migration in isoproterenol-treated cardiac myofibroblasts by downregulating the TGFβ/Smad3 signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: